Three-year multicenter surveillance of systemic pneumococcal infections in children

Pediatrics

Volumn 102, Issue 3 I, 1998, Pages 538-545

  Kaplan, Sheldon L ^a,i   Mason Jr , Edward O ^a   Barson, William J ^b   Wald, Ellen R ^c   Arditi, Moshe ^d   Tan, Tina Q ^e   Schutze, Gordon E ^f   Bradley, John S ^g   Givner, Laurence B ^h   Kim, Kwang Sik ^d   Yogev, Ram ^e  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Antibiotic resistance; Outcome; Streptococcus pneumoniae

Indexed keywords

CEFTRIAXONE; PENICILLIN DERIVATIVE;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; HUMAN; INFANT; INFECTION RATE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ADOLESCENT; BACTEREMIA; CEFTRIAXONE; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; HUMANS; INFANT; PENICILLINS; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; UNITED STATES;

EID: 17444450054     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.102.3.538     Document Type: Article

References (51)

1. Applebaum PC. Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae. Pediatr Infect Dis J 1996;15:932-939
2. Butler JC, Hofman J, Cetron MS, et al. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention Pneumococcal Sentinel Surveillance System. J Infect Dis. 1996;174:986-993
3. Zenni MK, Cheatham SH, Thompson JM, et al. Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. J Pediatr. 1995;127:533-537
4. Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J. 1995;14:745-750
5. Arnold KE, Leggiadro RJ, Breiman RF, et al. Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr. 1996;128:757-764
6. Hofman J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med. 1995;333: 481-486
7. Mason EO, Lamberth L, Lichenstein R, Kaplan SL. Distribution of Streptococcus pneumoniae resistant to penicillin in the USA and in-vitro susceptibility to selected oral antibiotics. J Antimicrob Chemother. 1995; 36:1043-1048
8. Tan TQ, Mason EO Jr, Kaplan SL. Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study. Pediatrics. 1993;92:761-767
9. Bradley JS, Kaplan SL, Klugman KP, Leggiadro RJ. Consensus: management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin. Pediatr Infect Dis J. 1995;14: 1037-1041
10. Friedland IR, McCracken GH Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med. 1994;331: 377-382
11. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Sixth informational supplement M1150-56. Wayne, PA: National Committee for Clinical Laboratory Standards; 1995
12. Minimum Inhibitory Concentration (MIC) Interpretive Standards (μg/ mL) for Streptococcus spp. Table 2C. M100-S7. Wayne, PA: National Committee for Clinical Laboratory Standards; 1997;17(2)
13. Zangwill KM, Vadheim CM, Vannier AM, Hemenway LS, Greenberg D, Ward JI. Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis. 1996;174:752-759
14. Eskola J, Takala AK, Kela E, Pekkanen E, Kalliokoski R, Leinonen M. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA. 1996;268:3323-3327
15. Dagan R, Englehard D, Piccard E, and the Israeli Pediatric Bacteremia and Meningitis Group. Epidemiology of invasive childhood pneumococcal infections in Israel. JAMA. 1992;268:3328-3332
16. Rothrock G, Billman L, Harrison L, et al. Progress toward elimination of Haemophilus influenzae type b disease among infants and children: United States, 1987-1995. MMWR. 1996;45:901-906
17. Naraqi S, Kirkpatrick GP, Kabins S. Relapsing pneumococcal meningitis: isolation of an organism with decreased susceptibility to penicillin G. J Pediatr. 1974;85:671-673
18. Parades A, Taber LH, Yow MD, Clark D, Nathan W. Prolonged pneumococcal meningitis due to an organism with increased resistance to penicillin. Pediatrics. 1976;58:378-381
19. Ahronheim GA, Reich B, Marks MI. Penicillin-insensitive pneumococci. Case report and review. Am J Dis Child. 1979;133:187-191
20. Gartner JC, Michaels RH. Meningitis from a pneumococcus resistant to penicillin. JAMA. 1979;241:1707-1709
21. Bradley JS, Connor JD. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr Infect Dis J. 1991;10:871-873
22. Sloas MM, Barrett FF, Chesney PJ, et al. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 1992;11:662-666
23. Friedland IR, Shelton S, Paris M, et al. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 1993;12:196-200
24. Kleiman MB, Weinberg GA, Reynolds JK, Allen SD. Meningitis with beta-lactam resistant Streptococcus pneumoniae: the need for early repeat lumbar puncture. Pediatr Infect Dis J. 1993;12:782-784
25. John CC. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin Infect Dis. 1994;18:188-193
26. Guibert M, Chahime H, Petit J, Odiévre M, Labrum P. Failure of cefotaxime treatment in two children with meningitis caused by highly penicillin-resistant Streptococcus pneumoniae. Acta Paediatr. 1995;84: 831-333
27. American Academy of Pediatrics, Committee on Infectious Diseases. Therapy for children with invasive pneumococcal infections. Pediatrics. 1997;99:289-299
28. Spika JS, Facklam RR, Pilikaytis BD, Oxtoby MJ, and the Pneumococcal Surveillance Working Group. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J Infect Dis. 1991;163: 1273-1278
29. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA. 1994;271:1831-1835
30. Anonymous. Report of the American Society for Microbiology Task Force on Antibiotic Resistance. Antimicrob Agents Chemother. 1995;39: 1-23
31. Jernigan DB, Cetron MS, Breiman RF. Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP): a strategy from the DRSP Working Group. JAMA. 1996;275:206-209
32. Pestotnik SL, Classen DC, Evans RS, et al. Implementing antibiotic practice guidelines through computer-associated decision support: clinical and financial outcomes. Ann Intern Med. 1996;124:884-890
33. Adcock PM, Sanders CL, Marshall GS. Effect of Practice Guidelines on the Management of Children Hospitalized With Bronchiolitis. Abstract of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 18, 1996; New Orleans, LA. Abstract N7
34. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 1995;273: 214-219
35. Dowell SF, Marcy SM, Phillips WR, Gerber MA, Schwartz B. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics. 1998;101:163-165
36. Weisholtz SJ, Hartman BJ, Roberts RB. Effect of underlying disease and age on pneumococcal serotype distribution. Am J Med. 1983;75:199-205
37. Ahman H, Kayhty H, Tamminen P, Vuorela A, Malinoski F, Eskola J. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants. Pediatr Infect Dis J. 1996;15:134-139
38. Käyhty H, Åhman H, Rönnberg P-R, Tillikainen R, Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis. 1995;172:1273-1278
39. Report of the Committee on Infectious Diseases. 1997 Red Book. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997:416-418
40. Peter G, Klein JO. Pneumococcal vaccine. Pediatr Rev. 1996;17:335-341
41. Jackson MA, Shelton S, Nelson JD, McCracken GH Jr. Relatively penicillin-resistant pneumococcal infections in pediatric patients. Pediatr Infect Dis. 1987;3:129-132
42. Friedland IR, Klugman KP. Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child. 1992;146:920-923
43. Tan TQ, Mason EO Jr, Kaplan SL. Systemic infection due to Streptococcus pneumoniae relatively resistant to penicillin in a children's hospital: clinical management and outcome. Pediatrics. 1992;90:928-933
44. Trang JM, Jacobs RF, Kearns GL, et al. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis. Antimicrob Agents Chemother. 1985;28:791-795
45. Del Rio M, McCracken GH Jr, Nelson JD, Chrane D, Shelton S. Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis. Antimicrob Agents Chemother. 1982;22:622-627
46. Chesney PJ, Williams JA, Presbury G, et al. Penicillin-and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell disease. J Pediatr. 1995;127:526-532
47. Plouffe JF, Breiman RF, Flacklam RR, for the Franklin County Pneumonia Study Group. Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. JAMA. 1996;275:194-198
48. Frankel RE, Virata M, Hardalo C, Altice FL, Friedland G. Invasive pneumococcal disease: clinical features, serotype, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin Infect Dis. 1996;23:577-584
49. Garcia-Leoni ME, Cercenado E, Rodeño P, Quirós JCLB, Martiñez-Hernandez D, Bouga E. Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis. 1992;14:427-435
50. Canatalà J, Marron A, Fernández-Sevilla A, Liñares J, Gudiol F. Treatment of penicillin-resistant pneumococcal bacteremia in neutropenic patients with cancer. Clin Infect Dis. 1997;24:148-152
51. Friedland IR. Comparison of the responses to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J. 1995;14:885-890